 |
entospletinib |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102 |
| |
entospletinib |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102 |